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Background: Chlamydia psittaci is a gram-negative, obligate intracellular organism. Birds are the main reservoir,
but also non-avian domestic animals and humans can be infected. In humans it mostly causes respiratory in-
fections due to occupational exposure with varying severity. Sensitive and speciﬁc diagnostic tests are needed to
deﬁne psittacosis in humans as these tests also allow rapid tracing of the animal source. However, diagnosis in
humans is often based on time-consuming culture techniques and antibody detection assays as in many coun-
tries, the existing molecular diagnostic tests for psittacosis are not reimbursed by the public health insurance.
Case presentation: An 82-year old female was referred to the hospital with a non-productive cough since four
weeks and since one week fever up to 39 °C, myalgia, generalized skin rash, acral edema and generalized
weakness under treatment with moxiﬂoxacin. Blood analysis showed signs of inﬂammation with mild eosino-
philia. Chest CT showed multiple peripheral ground glass opacities with consolidation in both lungs. Pulmonary
function testing only showed a mild decrease in diﬀusion capacity. Viral and bacterial serology were negative. As
the patient kept a pet parakeet for over ten years, a nested PCR for C. psittaci was performed on a nasopharyngeal
swab of the patient and on feces of the parakeet. Both returned positive for the same genotype. Genotyping was
performed by a genotype-speciﬁc real-time PCR. The patient fully recovered after a ten-day course of azi-
thromycin.
Conclusion: Due to non-speciﬁc signs during psittacosis, early detection of the infection and diﬀerentiation from
hypersensitivity pneumonitis can be challenging. Culture and antibody titers for C. psittaci have a lower sensi-
tivity than PCR-testing due to several factors. We present a case of human psittacosis (presenting as pneumonia)
with diagnosis based on clinical ﬁndings conﬁrmed by means of nested PCR. This case suggests the added value
of PCR in suspect cases despite negative serology. Our current paper underlines the need for a broader im-
plementation of PCR for early diagnosis of human psittacosis and thus early initiation of correct antibiotic
treatment with reduction of morbidity and mortality.
1. Case description
An 82-year old female patient was referred to the hospital with the
following symptoms that had lasted for a week: fever up to 39 °C,
myalgia, a generalized skin rash, edema of the hands and feet and
generalized weakness. These symptoms were preceded by bronchitis
with non-productive cough that developed 4 weeks before, for which
she had been treated with oral amoxicillin during 1 week. At the time of
admission she was taking oral moxiﬂoxacin.
There were no other people in her environment with similar com-
plaints. Her medical history included a cholecystectomy, a hyster-
ectomy per vaginam, and a pyelonephritis. There were no speciﬁc
familial antecedents. There was no history of nicotine, alcohol or drug
abuse. There were no known allergies. She had been keeping a small
parakeet (Pyrrhura molinea molinea) as a pet for over 10 years. The bird
did not show any signs of illness, nor had he been ill in the past.
2. Clinical examination
On admission, the patient had a systolic blood pressure of 140 and a
diastolic blood pressure of 70millimeter of mercury, a heart rate of 77
beats per minute, an axillar temperature of 37.8 °C and a blood oxygen
level of 96% on pulse oximetry. General inspection showed generalized
erythema and diﬀuse edema, most notably on the limbs and trunk
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(Fig. 1). Fine inspiratory crackles could be heard across both lower lung
ﬁelds. Further clinical examination showed no abnormalities.
3. Technical investigations
Blood analysis showed an elevated C-reactive protein (CRP) (166.7
mg/L) and a sedimentation rate of 57 mm/h. There was limited leu-
kocytosis (10300/μL) and an elevated eosinophilic count (309/μL).
Liver enzymes were elevated, with an SGOT of 69 U/L, an SGPT of 88
U/L, a gamma-GT of 115 U/L and alkaline phosphatase of 414 U/L.
Bilirubin levels were normal. Auto-immune serology including rheu-
matoid factor, anti-Cyclic Citrullinated Peptide antibodies, Anti-
Nuclear Factor and Antineutrophil Cytoplasmic Antibodies were nega-
tive. Viral serology including Cytomegalovirus, measles, Inﬂuenza A and
B, Varicella zoster, Adenovirus, Herpes simplex and Enteroviridae was ne-
gative. Bacterial serology including Mycoplasma pneumoniae and
Chlamydia pneumoniae returned negative as well (Table 1).
Chest X-ray revealed a diminished transparency of the perihilar lung
tissue, and on the proﬁle incidence an ill-deﬁned pneumonic inﬁltrate
could be discerned at the posterobasal region (Fig. 2).
Computed Tomography (CT) scan of the chest was performed,
which clearly showed multiple peripheral ground-glass opacities with
consolidation in both lungs (Fig. 3). Pulmonary function tests showed a
normal Forced Vital Capacity (FVC), FEV1 (Forced Expiratory Volume
in 1 second) and FEV1/FVC (Tiﬀeneau Index) and a mild decrease in
diﬀusion capacity (77% of expected value). Transthoracic cardiac
echography and abdominal echography revealed no abnormalities. A
Doppler ultrasound of the lower limbs showed only diﬀuse sub-
cutaneous edema, no signs of deep venous thrombosis.
Urine culture, sputum culture and repeated aerobic and anaerobic
blood cultures revealed no speciﬁc pathogen. Legionella antigen testing
on urine was negative.
4. Diﬀerential diagnosis
In summary, this patient was admitted to the hospital with a recent
history of non-productive cough progressing into a generalized condi-
tion with fever, myalgia, diﬀuse rash and edema of the limbs. Imaging
showed diﬀuse patchy inﬁltrates on both lungs. Blood sampling re-
vealed CRP elevation and mild eosinophilia, while routine virological,
bacteriological and auto-immune serology were negative. The following
entities were considered in the diﬀerential diagnosis:
4.1. Atypical pneumonia
The term 'atypical pneumonia' originates from descriptions in the
early part of the last century of a community-acquired pneumonia
syndrome distinct from the typical features of acute illness with fever
and mucopurulent sputum. It is characterized traditionally by initial
systemic complaints, relatively mild respiratory symptoms and scant
sputum production. Progression to an illness of varying severity with
possible extrapulmonary involvement and unresponsiveness to peni-
cillin can occur. Among atypical pathogens, Mycoplasma pneumoniae,
Legionella spp., Chlamydia pneumoniae, Chlamydia psittaci and Coxiella
burnetii are considered key pathogens in this concept [1].
4.2. Hypersensitivity pneumonitis
Hypersensitivity pneumonitis, also called extrinsic allergic alveo-
litis, is a respiratory condition involving the lung parenchyma and more
speciﬁcally the alveoli, terminal bronchioli and alveolar interstitium.
The underlying cause is a delayed allergic reaction secondary to re-
peated and prolonged inhalation of organic dust or other substances.
Hypersensitivity pneumonitis can be divided in an acute, subacute and
chronic type, depending on the intensity and the frequency of exposure
to the causative antigen [2]. With respect to our patient, exposure to
organic dust is documented in the form of avian feces-derived dust. She
was keeping a pet parakeet for over 10 years and regularly cleaning the
bird's cage, which would predispose her to immune sensitization and
the development of hypersensitivity pneumonitis. Her symptoms, in-
cluding fever and myalgia, are compatible with the acute/subacute
List of abbreviations
CRP C-reactive protein
CT computed tomography
FEV1 forced expiratory volume in 1 second
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DRESS drug reaction with eosinophilia and systemic symptoms
PCR polymerase chain reaction
ompA outer membrane protein A
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Fig. 1. Edema of the lower limbs with diﬀuse maculopapular rash.
Table 1
Routine serology results showing absence of acute humoral response to viral or atypical
respiratory pathogens.
IgG IgM
Viral Serology
CMV − −
Measles + −
Adenovirus + −
Inﬂuenza A − −
Inﬂuenza B + −
Varicella Zoster + (612 IU/mL) −
Herpes Simplex + −
Epstein Barr + (105 U/mL) −
Enterovirus − −
Bacterial Serology
Mycoplasma pneumoniae − −
Chlamydia pneumoniae − −
Coxiella burnetti − −
Chlamydia psittaci − −
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manifestation of hypersensitivity pneumonitis [2]. CT-graphic char-
acteristics of an acute/subacute hypersensitivity pneumonitis include
patchy or diﬀuse ground-glass opacities, lobular areas of decreased
attenuation or air-trapping and small centrilobular nodules. Chest CT of
our patient shows a similar image. In contrast, chronic hypersensitivity
pneumonitis is characterized by the development of ﬁbrotic changes
with thickening of the interlobular septa, intralobular reticulation and
traction bronchiectasis [2].
4.3. Paraneoplastic syndrome
Paraneoplastic syndromes include speciﬁc dermatologic and rheu-
matologic manifestations such as erythroderma and dermatomyositis.
Dermatomyositis is an inﬂammatory myopathy associated with
multiple skin changes which occur before the onset of proximal muscle
weakness. Possible skin eruptions are a heliotrope rash on the upper
eyelids, an erythematous rash on the face, neck, back, chest and
shoulders and Gottron papules (small purple or red ﬂat papules on
extensor surfaces, particularly present on the elbows and joints of the
hand). 10–25% of all cases of dermatomyositis are paraneoplastic.
Biochemical changes include high inﬂammatory markers and an ele-
vated level of creatine phosphokinase. Patients with erythroderma
show an erythematous and exfoliating diﬀuse rash, which is often
pruritic. The diagnosis can be conﬁrmed by performing a skin biopsy
[3,4].
Our patient showed a distal muscle weakness, most prominently
localized in the lower limbs. She also showed a skin rash which was
limited to the upper and lower limbs and some parts of the trunk. There
was no pruritus. Laboratory tests did not show an elevated creatinine
phosphokinase. However, the lung parenchymal changes CT are not
suggestive for an underlying malignancy.
4.4. DRESS-syndrome (drug reaction with eosinophilia and systemic
symptoms)
DRESS-syndrome is a severe adverse drug induced reaction which is
potentially life threatening. Symptoms include a severe skin eruption,
fever, hematological abnormalities (eosinophilia or atypical lympho-
cytosis) and internal organ involvement. Symptoms typically occur 2–6
weeks after the initiation of the drug therapy and persistence or ag-
gravation of the symptoms despite discontinuation of the culprit drug is
possible. The diagnosis of DRESS is challenging because of the diversity
of the clinical manifestations concerning skin eruption and the various
internal organs that can be involved. Many drugs can be responsible for
the development of a DRESS-syndrome, including amoxicillin [5,6].
Our patient had been taking amoxicillin during one week when symp-
toms appeared, including skin rash, fever and eosinophilia. Pulmonary
involvement however is not very common in classical DRESS syndrome.
The timeframe was not very suggestive as the pulmonary symptoms,
presumably related to the radiological anomalies, preceded the start of
amoxicillin.
In our patient, imaging was compatible with an atypical infectious
pneumonia, yet serology for M. pneumoniae, C. pneumoniae and viral
pathogens was negative. Since there was a positive history of contact
with psittacine birds, in this case her pet parakeet, further testing for C.
psittaci was performed on a nasopharyngeal swab. A nested polymerase
chain reaction (PCR) assay [7] speciﬁc for C. psittaci turned out posi-
tive. The PCR detects the outer membrane protein A (ompA) gene of C.
psittaci. The ompA gene encodes for the major outer membrane protein
(MOMP) of C. psittaci. Additionally, the nested PCR assay performed on
the parakeet's feces was positive as well for C. psittaci. Serological
testing in patient serum however was negative, which can be due to
several factors, as discussed further. Molecular characterization of C.
psittaci by an ompA genotyping real-time PCR for C. psittaci [8], revealed
the presence of genotype A in both the patient and the pet bird.
5. Treatment and clinical outcome
The therapy with moxiﬂoxacin was continued after admission to our
ward. However, as clinical improvement was lacking, and given the
systemic manifestations with eosinophilia as sign of generalized im-
mune hyperactivation, a decision was made to add oral glucocorticos-
teroids (methylprednisolone 32 mg with progressive tapering). After
one day a signiﬁcant positive eﬀect on the fatigue and myalgia was
noticed. As soon as the results of the PCR came in a few days later,
showing an infection with C. psittaci, a treatment with azithromycin
during ten days was given afterwards to prevent relapse. The patient
recovered completely from this episode with normalization of labora-
tory value and diﬀusion capacity upon outpatient evaluation 4 weeks
after hospital discharge.
Fig. 2. Chest X-ray, proﬁle incidence, at ﬁrst presentation showing patchy retrocardial
inﬁltrate.
Fig. 3. Computed tomography (CT) scan after one week of treatment with a beta-lactam
antibiotic.
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The parakeet was taken on by new owners and was treated with
doxycycline drops in its drinking water during four weeks. Afterwards a
new fecal swab was obtained and nested PCR was performed which was
negative for C. psittaci.
6. Background on Chlamydia psittaci pneumonia
6.1. Microbiological features
All micro-organisms in the family of the Chlamydiaceae are gram-
negative, obligate intracellular organisms. This family currently in-
cludes one genus – Chlamydia – which contains a total of eleven species
[9]. Originally, C. psittaci comprised nine ompA genotypes designated A
to F, E/B, M56, and WC [10]. Later on, six additional genotypes found
in psittacines and wild birds and designated 1V, 6N, Mat116, R54, YP84
and CPX0308 were proposed [11]. These pathogens have adapted to a
broad range of hosts, including mammals and avian species. They are
characterized by a biphasic life cycle, consisting of a metabolically in-
active, infectious form and a metabolically active, non-infectious form,
respectively called the elementary body and the reticulate body. To
characterize the diﬀerent genotypes within the avian C. psittaci species,
an analysis of the MOMP encoding outer membrane protein A gene
(ompA) is performed. These genotypes are relatively host speciﬁc.
Genotypes A and B are most often found in psittacine birds and pigeons,
respectively, genotype C in ducks and geese and D in turkeys. Genotype
F has been found in both psittacine birds and turkeys, and genotype E
has been found in a wide variety of hosts including pigeons, ratites,
ducks, turkeys and occasionally humans. Genotype E/B has been found
most frequently in ducks and the WC and M56 genotypes have been
isolated from cattle and muskrats. All these genotypes can be trans-
mitted to humans and could potentially cause severe disease [12–16].
6.2. Epidemiology and transmission
Most cases of psittacosis are sporadic occupational infections, most
commonly seen in young and middle-aged adults. Local outbreaks occur
from time to time. In most countries cases of human psittacosis must be
reported. Unfortunately ﬁgures of these reports probably vastly un-
derestimate the real burden of this disease as not all infections present
as pneumonia and remain undetected. In Belgium (comparable to other
European countries), for instance, only around ten human cases are
reported each year, despite a very high prevalence in poultry [12]. The
disease can be found in avian species –which are the primary reservoir-
but also in non-avian domestic animals and humans. As already men-
tioned, C. psittaci is classiﬁed in diﬀerent genotypes which display some
preference for certain host species [14,17]. C. psittaci infections can
occur in many diﬀerent bird species, spanning 30 diﬀerent bird orders.
Psittacidae (which include parakeets, parrots, cockatoos and lories), and
Columbiformes (pigeons) seem to be most commonly aﬀected [17–19].
The disease manifestations in infected birds can vary from asymp-
tomatic shedding of micro-organisms to pneumo-enteritis. Latency of
the infection with a possible reactivation in situations of stress is de-
scribed [17]. The organism is excreted in feces and nasal discharges of
infected birds and the organism can remain infectious in the environ-
ment for months. Transmission from birds to humans most commonly
occurs through inhalation of contaminated particles. Mouth-to-beak
contact or handling of infected birds' plumage or tissues can also lead to
infection [17,19,20].
6.3. Typical clinical presentation
Infection with Chamydia psittaci in humans mainly causes re-
spiratory infection. Clinical symptoms can be highly variable with in-
volvement of diﬀerent organs. The incubation period usually varies
between 5 and 14 days but exceptions involving a longer incubation
time have been described. The most frequently reported clinical
symptoms are high fever, chills, malaise, headache, myalgia, non-pro-
ductive cough and respiratory distress [12,14]. Gastro-intestinal
symptoms or rash can also be seen. Rare complications include myo-
carditis, encephalitis, hepatitis, keratoconjunctivitis, acute respiratory
distress syndrome and multiple organ failure, and C. psittaci could
possibly be linked to the development of ocular lymphoma [12,14].
With the modern availability of antibiotics, lethal cases of human
psittacosis have become extremely infrequent. However, severe or life-
threatening disease can occur when the initial signs of psittacosis are
not recognized and treatment is delayed [14]. Hematological leuko-
penia grade 1–2 can occur during the acute phase of the disease.
Augmented CRP and liver enzyme levels in psittacosis patients seem to
correlate with the severity of the infection. In most of hospitalized
patients, chest X-ray shows abnormalities. Unilateral lower lobe con-
solidation is the most common but bilateral consolidates, multiple
nodular inﬁltrates or miliary spreading can be found as well [21].
6.4. Diagnosis
Any positive history of contact with birds and a suggestive clinical
presentation should rise suspicion for an infection with C. psittaci. A
case of human psittacosis can be conﬁrmed if the clinical ﬁndings are in
concordance with psittacosis and a laboratory conﬁrmation [12]. In the
past, a laboratory conﬁrmation was said to be obtained by at least one
of the following methods: (i) isolation of the causative agent from re-
spiratory secretions, (ii) four-fold or more increase of antibody titer
between paired sera by complement ﬁxation test or the more sensitive
micro-immunoﬂuorescence test or (iii) detection of IgM antibodies
against C. psittaci using a micro-immunoﬂuorescence test to a reciprocal
titer of 16 or more. However, negative serology in hospitalized psitta-
cosis patients is not uncommon. The current serological tests are less
sensitive than PCR. Moreover serology can be negatively inﬂuenced by
antibiotic use and by genetic variations in Toll-like receptors and nu-
cleotide oligomerization domain-like receptors, leading to inadequate
recognition of Chlamydia by the host immune system [22]. However, in
most countries, human psittacosis is a notiﬁable disease. In case of a
notiﬁable disease, speciﬁc and rapid diagnosis in humans is required in
addition to source tracing to prevent further spreading of the infection.
This is the reason why in the past decade, diagnostic C. psittaci PCR
assays were developed and are currently being introduced in the rou-
tine clinical setting. PCR is not only more sensitive than culture and
serology, it also allows genotyping, which assists in source tracing as C.
psittaci is currently divided into genotypes (A-F, E/B, M56 and WC), all
more or less associated with a preferred avian host [13].
6.5. Therapeutic approach and prognosis
Human cases of psittacosis are preferably treated with tetracyclines,
including doxycycline or tetracycline hydrochloride. This treatment
must be continued during a period of at least 10–14 days in order to be
eﬀective and to prevent relapse. When treatment with tetracyclines is
contra-indicated, macrolides are probably the best alternative [12,19].
Quinolones may also be a treatment alternative, but they are less active
against C. psittaci than tetracyclines and macrolides [17,19,23].
As for the avian reservoir, treatment or extermination is re-
commended to prevent further spreading. Isolation in a clean cage with
proper husbandry is recommended and doxycycline is the antibiotic of
choice. There is no clear evidence of necessary length of treatment, but
21–30 days should suﬃce. In relation to potential outbreaks, retesting
with PCR is recommended after four weeks [19].
7. Conclusion
Due to the non-speciﬁc clinical signs that occur during an infection
with C. psittaci, early identiﬁcation of the disease can be challenging.
However, a history of frequent contact with psittacine bird species or
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pigeons, along with suggestive symptoms, should trigger additional
diagnostics for psittacosis in order to launch treatment in humans and
contact bird(s) as soon as possible. In the context of exposure to bird
droppings, diﬀerential diagnosis with hypersensitivity pneumonitis can
be diﬃcult. Our case stresses the added value of PCR and especially of
the genotype-speciﬁc real-time PCR on a human respiratory sample as
this test led us to the correct diagnosis, the correct treatment modality
and the infection source, being the pet bird. In many countries, the
existing molecular diagnostic tests for this entity are not yet reimbursed
by the public health insurance. We conclude that PCR-based testing in
suspect cases is valuable for early diagnosis and early initiation of
correct antibiotic treatment with reduction of morbidity and mortality
and should me more broadly implemented.
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